slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 6,991-7,020
Pages 395
Rows per page 30
Slide function
6,991-7,020 of 11,828
16
The chart shows revenue in millions. 2023 is a projected range.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
17
The chart is a waterfall-style progression showing margin improvement.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
18
The slide uses a bar chart to visualize the reduction in cash burn and a callout box for the current cash position.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
04
IBEX | Investor Presentation Deck | 18 slidesIBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Early Struggles1 hit
05
IBEX | Investor Presentation Deck | 18 slidesIBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Early Struggles1 hit
06
The slide highlights growth in profitability and cash flow despite a slight decrease in revenue.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Early Struggles1 hit
08
The slide uses a grid of icons to represent client industries, with ranking numbers (#1, #2) likely indicating client tier or relationship status.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Rising SuccessLoop · Voice Of Customer1 hit
12
The chart shows revenue growth for cohorts starting in FY19-FY23, with Year 2 and Year 3 data for recent cohorts being estimates.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Rising Success1 hit
13
The chart uses a trend arrow to emphasize the CAGR.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
14
The bar chart shows a clear trend of decreasing US revenue and increasing Offshore/Nearshore revenue over 2021-2023.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
09
The slide uses a timeline framework to demonstrate historical traction and partnership growth.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Solution1 hit
17
Slide compares two generations of therapy; includes clinical metrics like cORR and mDOR.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
23
Includes waterfall plot for BOR and spider plot for response over time. Data cut-off Sep 30, 2023.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
30
Includes waterfall plot and spider plot (longitudinal response). Data cut-off Sep 30, 2023.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
31
Includes p-values for statistical significance across four distinct clinical metrics.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
33
The slide uses a two-row layout to contrast GEN1 and GEN2 therapies, each with a 'Next Step' callout.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
52
Includes study design timeline, histology details, and comparative tumor volume charts (group averages vs individual mice).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
56
The chart uses a broken x-axis between -29 and 0. The legend indicates four distinct treatment groups.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
57
The slide uses a log-linear plot to demonstrate drug clearance over time.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
72
Includes waterfall plot and spider plot (change in tumor size over time).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
18
The chart demonstrates the mechanism of action: rapid cell expansion followed by clearance within 30 days, correlating with disease marker reduction.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Traction1 hit
25
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market Sizing1 hit
27
The slide uses a standard pharmaceutical pipeline table format, categorizing by clinical vs preclinical status and highlighting specific regulatory designations and trial results.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market Sizing1 hit
34
The slide uses a side-by-side comparison of two disease indications, showing clinical results, relevant competitor benchmarks, and market size.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
35
The chart demonstrates deepening clinical response over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
41
Slide contains three distinct charts comparing IMX-110 against standard of care in mouse models.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
43
Includes survival curves (Kaplan-Meier style), median survival bar charts, and bioluminescence imaging of tumor activity.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
45
The slide compares sarcoma patients against non-sarcoma patients using line charts for lesion size change and a bar chart for best percentage change.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
47
The slide presents clinical data for a small sample size (n=4).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
53
Includes two distinct sets of preclinical charts (tumor volume and survival curves) with detailed methodology in footnotes.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit